Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Althea Technologies
 More »

  • GEN | Biolinks
    Alimera Sciences Alkermes All India Bitoech Association Allergan Allinky Biopharma Allon Therapeutics Alnylam Pharmaceuticals Altathera Pharmaceuticals Althea Technologies, Inc. ...
  • Ajinomoto Moves into CDMO Market
    Ajinomoto agreed to take over Althea Technologies, a contract development and manufacturing organization (CDMO), by acquiring all of the company's capital stock for $175 million. ...
    3-6-2013
  • Pfenex Division Begins Product Capacity Expansion
    Last October, Pfenex awarded Althea Technologies a contract for the cGMP manufacturing of circumsporozoite protein from Plasmodium falciparum , a component of a vaccine for ...
    1-16-2013
  • Tackling Transfection Tasks
    ... co-founder and co-chairperson of Althea Technologies. "However, these methods are often cumbersome for patients to receive, and present difficulties in manufacturing and scale up." ...
    1-1-2013
  • Twisting and Turning for Better Protein Expression
    ... In October, Pfenex awarded Althea Technologies a contract for the GMP manufacturing of circumsporozoite protein, an important component of malaria vaccine. Althea will deploy a ...
    1-1-2013
  • People in the News
    , to its board of directors...Althea Technologies promoted Rick Hancock to president and CEO, Chris Duffy to svp of operations, and E.J. Brandreth to svp of quality and regulatory. ...
    11-1-2012
  • People in the News
    Dennis Fenton, Ph.D., is now chairman of Althea Technologies' scientific advisory board...Nile Therapeutics appointed Darlene Horton, M.D., as its CMO...Oncothyreon promoted Scott ...
    8-1-2012
  • People in the News
    Therapeutics appointed Bruce Carter, Ph.D. , to its board of directors...Althea Technologies hired Kristin DeFife, Ph.D. , as director, biologics manufacturing and Jack ...
    6-15-2012
  • Getting the Most from Outsourced Projects
    ... Supply Chain Risks Althea Technologies performs supplier assessments with the goal of making sure that raw materials meet all of its and its clients' expectations. "The biggest ...
    2-15-2012
  • Timing Is Everything in Protein Formulation
    ... protein drugs lie in sustained-release technologies such as micro- and nanoparticles, ... Klyushnichenko adds. Crystalline Work-Around Althea has expertise in formulations such as ...
    9-15-2011
  • Tackling DNA Vaccine Production
    ... Ledent stated. Plasdmid DNA Purification Scale-Up Scientists at Althea Technologies are working to ensure that plasmid preparations are stable at room temperature. The firm has ...
    9-1-2011
  • DNA Vaccines Hit Their Stride with Approvals Anticipated
    ... Accelerating Commercialization Althea Technologies has developed a high cell density fermentation and purification process for plasmid DNA products that reportedly provides plasmid ...
    4-15-2010
  • DNA Vaccines Inch Toward Human Use
    ... is eager to bring new approaches to unmet medical needs; approaches that are safe and effective," noted E.J. Brandreth, vp of quality and regulatory affairs at Althea Technologies. ...
    3-1-2009
  • Althea and Protein'eXpert to Couple Respective Manufacturing...
    Althea Technologies and Protein'eXpert plan on offering their services under a complementary commercialization partnership. While Althea Technologies provides manufacturing ...
    7-7-2008
  • Bioprocess Advances Aim to Streamline Operations
    ... Althea Technologies discussed its cGMP contract production of recombinant proteins, DNA-based therapeutics, and vaccines as well as commercial formulation and aseptic filling ...
    5-1-2008

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll